Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Key Insights on Hims & Hers Health Stock

Shares of Health Care sector company Hims & Hers Health moved 5.1% today, and are now trading at a price of $42.55. The Mid-Cap stock's daily volume was 18,373,598 compared to its average volume of 15,780,001. The S&P 500 index returned a -1.0% performance.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company is based in San Francisco and has 1,046 full time employees. Its market capitalization is $9,296,281,600.

Over the last year, HIMS's share price has increased by 327.6%, which represents a difference of 307.6% when compared to the S&P 500. The stock's 52 week high is $46.01 per share whereas its 52 week low is $9.14. Hims & Hers Health has averaged free cash flows of $-17523400.0 over the last 4 years, but they have been increasing at a rate of 24.7%. Nonetheless, more cautious investors will probably avoid this stock until the business becomes firmly cash positive.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 73,483 17,220 56,263 292.39
2022 -26,531 2,714 -29,245 17.02
2021 -34,412 832 -35,244 -735.96
2020 -2,479 1,737 -4,216 94.39
2019 -74,867 308 -75,175
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS